Cerebrospinal fluid xanthochromia with rifampin

S. Liggett,J. Berger,Jubran A. Hush

DOI: https://doi.org/10.1002/ana.410120240

IF: 11.2

1982-08-01

Annals of Neurology

Abstract:myelography and cisternography. One hour later she became lethargic but remained oriented. Neurological examination revealed scanning dysarthria, primary-position downbeat nystagmus, and diminishcd tone and deep tendon reflexes in all extremities, as well as dysmetria, ataxia, and impaired rapid alternating movements in the limbs. After one hour her neurological status had returned to normal. Carbamazepine, phenytoin, and phenobarbitol levels at the onset of symptoms were 8.2, 22.2, and 6.7 pgiml, respectively. Metrizamide cisternography accompanied by CT scan with 5 mm sections was normal. When plasma anticonvulsant levels were undetectable, and with the patient's consent, carbamazepine was restarted and plasma levels were measured at various times over the next two days (Figure). Anticonvulsant levels were determined using high-performance liquid chromatography (Samuels SD, Ramsay RE, Vasquez D, Sonni R: Micromethod for anticonvulsant determination from whole blood spotted on filter paper. Submitted for publication). The unbound fractions were assayed from plasma ultrafiltrates obtained using Amicon ultrafiltration cones. O n the morning of the second day the patient developed symptoms of dysarthtia. downbeat nystagmus in primary position, limb dysmetria, truncal ataxia, and diminished deep tendon reflexes two hours after ingesting carbamazepine. At the onset of symptoms her plasma carbamazepine level was 15.0 pgiml; two hours later, when the symptoms had cleared, it was 15.8 pgiml. The corresponding free carbamazepine level was 2.6 pgiml at the onset of symptoms, with the highest level, 3.1 pgiml, occurring one hour later. The percentage of free carbamazepine for all the samples was 15.86 * 2.65 SD. Most drug-induced nystagmus is evident in lateral and upward gaze 141, but i t may occur also with downgaze. Primary-position downbeat nystagmus has been associated with structural lesions of the craniocervical junction [ 3 , 41, while upbeat nystagmus accompanies lesions of the superior cerebellar vermis o r rectum [Sl. Common toxic symptoms from carbamazepine are diplopia, drowsiness, headaches, and ataxia, but these have not always correlated well with blood levels [ S ] . Sullivan et a1 [7] reported "bilateral vertical nystagmus on upgaze" in a patient who had awakened from coma, at a time when the carbamazepine level was approximately 10 pgiml. O u r patient, similar to those reported by Alpert [ I ] , had no evidence of a structural abnormality. All the patients reported by Alpert and by Sullivan et a1 had taken more than one medication, whereas the patient reported here developed similar symptoms when given carbamaz6pine either alone or in combination with phenytoin and phenobarbital. Pharmacokinetic principles suggest that the brain concentration o f a drug is proportional to its free serum concentration. Our patient's clinical symptoms were indeed more closely related to the unbound fraction of the drug, occurring with levels above 2.6 pgiml. The protein binding of 84.3% in o u r patient (normal, 70 to 80%) may explain why plasma levels well above the therapeutic range were attained before symptoms developed.